S.C. Ropharma's earnings have been declining at an average annual rate of -37.2%, while the Consumer Retailing industry saw earnings declining at 30.7% annually. Revenues have been growing at an average rate of 13.4% per year. S.C. Ropharma's return on equity is 2.7%, and it has net margins of 0.2%.
How S.C. Ropharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BVB:RPH Revenue, expenses and earnings (RON Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
1,595
4
229
0
31 Dec 25
1,538
2
228
0
30 Sep 25
1,468
3
224
0
30 Jun 25
1,430
0
224
0
31 Mar 25
1,377
-1
218
0
31 Dec 24
1,323
-2
211
0
30 Sep 24
1,255
-1
204
0
30 Jun 24
1,187
0
198
0
31 Mar 24
1,154
4
191
0
31 Dec 23
1,120
8
185
0
30 Sep 23
1,099
9
178
0
30 Jun 23
1,078
10
171
0
31 Mar 23
1,040
10
164
0
31 Dec 22
1,002
9
157
0
30 Sep 22
976
10
153
0
30 Jun 22
951
12
149
0
31 Mar 22
919
11
146
0
31 Dec 21
888
11
143
0
30 Sep 21
857
10
138
0
30 Jun 21
826
9
134
0
31 Mar 21
816
8
129
0
31 Dec 20
806
7
125
0
30 Sep 20
787
6
122
0
30 Jun 20
769
5
118
0
31 Mar 20
776
6
115
0
31 Dec 19
784
8
112
0
30 Sep 19
774
8
114
0
30 Jun 19
764
9
115
0
31 Mar 19
700
11
111
0
31 Dec 18
636
12
106
0
30 Sep 18
596
12
100
0
30 Jun 18
555
12
94
0
31 Mar 18
545
12
94
0
31 Dec 17
535
12
94
0
30 Sep 17
532
12
89
0
30 Jun 17
530
13
85
0
31 Mar 17
519
12
82
0
31 Dec 16
507
10
79
0
31 Dec 15
471
9
62
0
Quality Earnings: RPH has high quality earnings.
Growing Profit Margin: RPH became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RPH's earnings have declined by 37.2% per year over the past 5 years.
Accelerating Growth: RPH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: RPH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (2.8%).
Return on Equity
High ROE: RPH's Return on Equity (2.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/06 08:05
End of Day Share Price
2026/07/03 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
S.C. Ropharma S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.